IBDEI0PV ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11538,0)
 ;;=H44.2A1^^77^737^37
 ;;^UTILITY(U,$J,358.3,11538,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11538,1,3,0)
 ;;=3^Degenerative Myopia w/ CNV,Right Eye
 ;;^UTILITY(U,$J,358.3,11538,1,4,0)
 ;;=4^H44.2A1
 ;;^UTILITY(U,$J,358.3,11538,2)
 ;;=^5151318
 ;;^UTILITY(U,$J,358.3,11539,0)
 ;;=H44.2A2^^77^737^38
 ;;^UTILITY(U,$J,358.3,11539,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11539,1,3,0)
 ;;=3^Degenerative Myopia w/ CNV,Left Eye
 ;;^UTILITY(U,$J,358.3,11539,1,4,0)
 ;;=4^H44.2A2
 ;;^UTILITY(U,$J,358.3,11539,2)
 ;;=^5151319
 ;;^UTILITY(U,$J,358.3,11540,0)
 ;;=H44.2A3^^77^737^39
 ;;^UTILITY(U,$J,358.3,11540,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11540,1,3,0)
 ;;=3^Degenerative Myopia w/ CNV,Bilateral
 ;;^UTILITY(U,$J,358.3,11540,1,4,0)
 ;;=4^H44.2A3
 ;;^UTILITY(U,$J,358.3,11540,2)
 ;;=^5151320
 ;;^UTILITY(U,$J,358.3,11541,0)
 ;;=H44.2B1^^77^737^40
 ;;^UTILITY(U,$J,358.3,11541,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11541,1,3,0)
 ;;=3^Degenerative Myopia w/ Mac Hole,Right Eye
 ;;^UTILITY(U,$J,358.3,11541,1,4,0)
 ;;=4^H44.2B1
 ;;^UTILITY(U,$J,358.3,11541,2)
 ;;=^5151322
 ;;^UTILITY(U,$J,358.3,11542,0)
 ;;=H44.2B2^^77^737^41
 ;;^UTILITY(U,$J,358.3,11542,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11542,1,3,0)
 ;;=3^Degenerative Myopia w/ Mac Hole,Left Eye
 ;;^UTILITY(U,$J,358.3,11542,1,4,0)
 ;;=4^H44.2B2
 ;;^UTILITY(U,$J,358.3,11542,2)
 ;;=^5151323
 ;;^UTILITY(U,$J,358.3,11543,0)
 ;;=H35.3133^^77^737^6
 ;;^UTILITY(U,$J,358.3,11543,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11543,1,3,0)
 ;;=3^Non-Exudative ARMD, Advanced Atrophic w/o SF, Bilateral
 ;;^UTILITY(U,$J,358.3,11543,1,4,0)
 ;;=4^H35.3133
 ;;^UTILITY(U,$J,358.3,11543,2)
 ;;=^5138513
 ;;^UTILITY(U,$J,358.3,11544,0)
 ;;=H35.3132^^77^737^5
 ;;^UTILITY(U,$J,358.3,11544,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11544,1,3,0)
 ;;=3^Non-Exudative ARMD, Intermediate Dry Stage, Bilateral
 ;;^UTILITY(U,$J,358.3,11544,1,4,0)
 ;;=4^H35.3132
 ;;^UTILITY(U,$J,358.3,11544,2)
 ;;=^5138512
 ;;^UTILITY(U,$J,358.3,11545,0)
 ;;=H35.3291^^77^737^9
 ;;^UTILITY(U,$J,358.3,11545,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11545,1,3,0)
 ;;=3^Exudative ARMD, w/ Active CNVM, Unspec Eye
 ;;^UTILITY(U,$J,358.3,11545,1,4,0)
 ;;=4^H35.3291
 ;;^UTILITY(U,$J,358.3,11545,2)
 ;;=^5138533
 ;;^UTILITY(U,$J,358.3,11546,0)
 ;;=H35.3292^^77^737^10
 ;;^UTILITY(U,$J,358.3,11546,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11546,1,3,0)
 ;;=3^Exudative ARMD, w/ Inactive CNVM, Unspec Eye
 ;;^UTILITY(U,$J,358.3,11546,1,4,0)
 ;;=4^H35.3292
 ;;^UTILITY(U,$J,358.3,11546,2)
 ;;=^5138534
 ;;^UTILITY(U,$J,358.3,11547,0)
 ;;=H35.3293^^77^737^11
 ;;^UTILITY(U,$J,358.3,11547,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11547,1,3,0)
 ;;=3^Exudative ARMD, w/ Inactive Scar, Unspec Eye
 ;;^UTILITY(U,$J,358.3,11547,1,4,0)
 ;;=4^H35.3293
 ;;^UTILITY(U,$J,358.3,11547,2)
 ;;=^5138535
 ;;^UTILITY(U,$J,358.3,11548,0)
 ;;=Z79.899^^77^737^33
 ;;^UTILITY(U,$J,358.3,11548,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11548,1,3,0)
 ;;=3^Plaquenil/Long Term Med Screening
 ;;^UTILITY(U,$J,358.3,11548,1,4,0)
 ;;=4^Z79.899
 ;;^UTILITY(U,$J,358.3,11548,2)
 ;;=^5063343
 ;;^UTILITY(U,$J,358.3,11549,0)
 ;;=Z91.5^^77^738^1
 ;;^UTILITY(U,$J,358.3,11549,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11549,1,3,0)
 ;;=3^Personal Hx of Suicide Attempt(s)
 ;;^UTILITY(U,$J,358.3,11549,1,4,0)
 ;;=4^Z91.5
